Skip to main content
Erschienen in: Acta Neuropathologica 3/2012

01.03.2012 | Correspondence

Asymmetry of neurodegenerative disease-related pathologies: a cautionary note

verfasst von: Harald Stefanits, Herbert Budka, Gabor G. Kovacs

Erschienen in: Acta Neuropathologica | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Excerpt

Alzheimer’s disease (AD) is characterized neuropathologically by the presence of amyloid plaques (Aβ) and neurofibrillary tangles (tau). In addition, molecular pathologic examinations revealed concomitant protein depositions (in particular TDP-43 or α-synuclein), in various combinations with AD associated pathology [8]. Earlier papers evaluating senile changes in the brain noted variable asymmetric pathology without predominance of either hemisphere [6]. Two further papers, one on the evaluation of 5 patients [14] and another on 56 [7] indicated differences between the left and right hippocampus; differences were highly significant for plaques, tangles and also for granulovacuolar degeneration. Diagnostic and staging criteria developed after these studies did not provide recommendations for the side to be evaluated [24, 10]. Furthermore, asymmetric distribution of neuronal loss and gliosis correlating with clinical symptoms (e.g., progressive aphasia or apraxia) is a feature of various molecular forms of frontotemporal lobar degeneration. Unilateral Creutzfeldt–Jakob disease has been also reported [15]. A recent comprehensive study indicated asymmetric involvement of the medial temporal lobe in patients with advanced argyrophilic grain disease [1]. …
Literatur
1.
Zurück zum Zitat Adachi T, Saito Y, Hatsuta H et al (2010) Neuropathological asymmetry in argyrophilic grain disease. J Neuropathol Exp Neurol 69:737–744PubMedCrossRef Adachi T, Saito Y, Hatsuta H et al (2010) Neuropathological asymmetry in argyrophilic grain disease. J Neuropathol Exp Neurol 69:737–744PubMedCrossRef
2.
Zurück zum Zitat Alafuzoff I, Arzberger T, Al-Sarraj S et al (2008) Staging of neurofibrillary pathology in Alzheimer’s disease: a study of the BrainNet Europe Consortium. Brain Pathol 18:484–496PubMed Alafuzoff I, Arzberger T, Al-Sarraj S et al (2008) Staging of neurofibrillary pathology in Alzheimer’s disease: a study of the BrainNet Europe Consortium. Brain Pathol 18:484–496PubMed
3.
Zurück zum Zitat Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112:389–404PubMedCrossRef Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112:389–404PubMedCrossRef
4.
Zurück zum Zitat Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239–259PubMedCrossRef Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239–259PubMedCrossRef
5.
Zurück zum Zitat Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24:197–211PubMedCrossRef Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24:197–211PubMedCrossRef
6.
Zurück zum Zitat Jamada M, Mehraein P (1968) Distribution of senile changes in the brain. The part of the limbic system in Alzheimer’s disease and senile dementia. Arch Psychiatr Nervenkr 211:308–324PubMedCrossRef Jamada M, Mehraein P (1968) Distribution of senile changes in the brain. The part of the limbic system in Alzheimer’s disease and senile dementia. Arch Psychiatr Nervenkr 211:308–324PubMedCrossRef
7.
Zurück zum Zitat Janota I, Mountjoy CQ (1988) Asymmetry of pathology in Alzheimer’s disease. J Neurol Neurosurg Psychiatry 51:1011–1012PubMedCrossRef Janota I, Mountjoy CQ (1988) Asymmetry of pathology in Alzheimer’s disease. J Neurol Neurosurg Psychiatry 51:1011–1012PubMedCrossRef
8.
Zurück zum Zitat Kovacs GG, Botond G, Budka H (2010) Protein coding of neurodegenerative dementias: the neuropathological basis of biomarker diagnostics. Acta Neuropathol 119:389–408PubMedCrossRef Kovacs GG, Botond G, Budka H (2010) Protein coding of neurodegenerative dementias: the neuropathological basis of biomarker diagnostics. Acta Neuropathol 119:389–408PubMedCrossRef
9.
Zurück zum Zitat McKeith IG, Dickson DW, Lowe J et al (2005) Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65:1863–1872PubMedCrossRef McKeith IG, Dickson DW, Lowe J et al (2005) Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65:1863–1872PubMedCrossRef
10.
Zurück zum Zitat Mirra SS, Heyman A, McKeel D et al (1991) The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer’s disease. Neurology 41:479–486PubMed Mirra SS, Heyman A, McKeel D et al (1991) The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer’s disease. Neurology 41:479–486PubMed
11.
Zurück zum Zitat Montine TJ, Phelps CH, Beach TG et al (2012) National Institute on Aging-Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach. Acta Neuropathol 123:1–11. doi:10.1007/s00401-011-0910-3 PubMedCrossRef Montine TJ, Phelps CH, Beach TG et al (2012) National Institute on Aging-Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach. Acta Neuropathol 123:1–11. doi:10.​1007/​s00401-011-0910-3 PubMedCrossRef
12.
Zurück zum Zitat Moossy J, Zubenko GS, Martinez AJ, Rao GR, Kopp U, Hanin I (1989) Lateralization of brain morphologic and cholinergic abnormalities in Alzheimer’s disease. Arch Neurol 46:639–642PubMedCrossRef Moossy J, Zubenko GS, Martinez AJ, Rao GR, Kopp U, Hanin I (1989) Lateralization of brain morphologic and cholinergic abnormalities in Alzheimer’s disease. Arch Neurol 46:639–642PubMedCrossRef
13.
Zurück zum Zitat Thal DR, Rub U, Orantes M, Braak H (2002) Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791–1800PubMed Thal DR, Rub U, Orantes M, Braak H (2002) Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791–1800PubMed
14.
Zurück zum Zitat Wilcock GK, Esiri MM (1987) Asymmetry of pathology in Alzheimer’s disease. J Neurol Neurosurg Psychiatry 50:1384–1386PubMedCrossRef Wilcock GK, Esiri MM (1987) Asymmetry of pathology in Alzheimer’s disease. J Neurol Neurosurg Psychiatry 50:1384–1386PubMedCrossRef
15.
Zurück zum Zitat Yamanouchi H, Budka H, Vass K Sr (1986) Unilateral Creutzfeldt-Jakob disease. Neurology 36:1517–1520PubMed Yamanouchi H, Budka H, Vass K Sr (1986) Unilateral Creutzfeldt-Jakob disease. Neurology 36:1517–1520PubMed
Metadaten
Titel
Asymmetry of neurodegenerative disease-related pathologies: a cautionary note
verfasst von
Harald Stefanits
Herbert Budka
Gabor G. Kovacs
Publikationsdatum
01.03.2012
Verlag
Springer-Verlag
Erschienen in
Acta Neuropathologica / Ausgabe 3/2012
Print ISSN: 0001-6322
Elektronische ISSN: 1432-0533
DOI
https://doi.org/10.1007/s00401-011-0936-6

Weitere Artikel der Ausgabe 3/2012

Acta Neuropathologica 3/2012 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.